医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.

广告
第一作者: Wei,Jiang
第一单位: Sydney Medical School, Faculty of Medicine and Health, and.;Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.
作者单位: Sydney Medical School, Faculty of Medicine and Health, and.;Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia. [1] Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia. [2] Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.;Blood Transplant and Cell Therapies Program, Department of Haematology, Westmead Hospital, Westmead, NSW, Australia. [3] Ramaciotti Facility for Human Systems Biology, and.;Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.;Infection, Immunity, and Inflammation Theme, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia. [4] Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.;School of Mathematics and Statistics, Faculty of Science, The University of Sydney, Sydney, NSW, Australia. [5] School of Mathematics and Statistics, Faculty of Science, The University of Sydney, Sydney, NSW, Australia. [6] Blood Transplant and Cell Therapies Program, Department of Haematology, Westmead Hospital, Westmead, NSW, Australia. [7] Sydney Medical School, Faculty of Medicine and Health, and.;Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.;Blood Transplant and Cell Therapies Laboratory, Institute for Clinical Pathology and Medical Research, NSW Health Pathology, Westmead, Australia. [8] Blood Transplant and Cell Therapies Laboratory, Institute for Clinical Pathology and Medical Research, NSW Health Pathology, Westmead, Australia. [9] Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia. [10] Department of Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.;Department of Medicine, University of Melbourne, Victoria, Australia. [11] Sydney Medical School, Faculty of Medicine and Health, and.;Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.;Oncology Unit and. [12] Sydney Medical School, Faculty of Medicine and Health, and.;Bone Marrow Transplant and Cell Therapies Unit, Children's Hospital at Westmead, Westmead, NSW, Australia. [13] Sydney Medical School, Faculty of Medicine and Health, and.;Westmead Institute for Medical Research, The University of Sydney, Westmead, NSW, Australia.;Blood Transplant and Cell Therapies Program, Department of Haematology, Westmead Hospital, Westmead, NSW, Australia. [14]
DOI 10.1182/bloodadvances.2022007103
PMID 35819448
发布时间 2022-11-05
提交
  • 浏览3
Blood advances

Blood advances

2022年6卷17期

4949-4966页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷